Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Zhejiang Hisun Pharmaceutical presents new RET inhibitors

Aug. 19, 2020

BrightGene Bio-Medical Technology identifies Gly12Cys mutant GTPase KRAS inhibitors

Aug. 19, 2020

T-2143, a novel HSP90-PI3K drug conjugate with promising activity in cancer models

Aug. 19, 2020

New MAP2K1 inhibitors patented by Betta Pharmaceuticals

Aug. 18, 2020

Sichuan Kelun-Biotech Biopharmaceutical synthesizes new camptothecin derivatives

Aug. 18, 2020

Aeovian Pharmaceuticals identifies new mTORC1 inhibitors

Aug. 17, 2020

New phosphodiesterase PDE3A and PDE3B inhibitors disclosed by Bayer, The Broad Institute

Aug. 17, 2020

Beijing Scitech-Mq Pharmaceuticals patents multitarget inhibitors

Aug. 17, 2020

Stromal cell subtypes identified in TNBC

Aug. 17, 2020

Debiopharm presents 3-year follow-up data from phase II study of Debio-1143

Aug. 14, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...